| Catalog No | N-7003 |
|---|---|
| Purity | ≥95% by AX-HPLC |
| Extinction Coefficient | 21,000 Lmol-1cm-1 at 254 nm |
| Molecular Formula | C22H32N10O18P3 (free acid) |
| Molecular Weight | 817.40 g/mole (free acid) |
| Salt Form | NH4+ |
| Concentration | 100 mM |
| Buffer | H2O |
| Recommended Storage | -20°C or below |
| Other Name(s) | Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G |
| Application | CRISPR, In vitro Transcription, Recombinases, TALENS, Transposases, Vaccine Development, Zinc Finger Nucleases |
| Backbone | 5'-5'-Triphosphate |
| Base Analog(s) | Guanosine |
| Nucleotide Category | Cap analogs |
ARCA (Anti-Reverse Cap Analog) This material and products incorporating it are sold under license from the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College and Dr. Edward Darzynkiewicz and may be used for research use only, excluding any use in humans or for any diagnostic or therapeutic purpose. U.S. Patent 7,074,596.
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission of Seller. No license under any patent or other intellectual property right of Seller or its licensors is granted or implied by the purchase unless otherwise provided in writing.
TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser's sole responsibility.
Filipowicz, W. . Functions of the 5,-terminal m7G cap in eukaryotic mRNA.
Banerjee, A. K. . 5'-terminal cap structure in eucaryotic messenger ribonucleic acids.
Kondrat, Jason; Sultana, Nishat; Zangi, Lior . Synthesis of Modified mRNA for Myocardial Delivery.
